714MO Datopotamab deruxtecan (Dato-DXd) in patients with endometrial (EC) or ovarian cancer (OC): Results from the phase II TROPION-PanTumor03 study

A. Oaknin, J.E. Ang, S.Y. Rha, K. Yonemori, R. Kristeleit, Chia‐Chin Lin, T. Satoh, P. Estevez Garcia, Mehmet Alı Nahıt Şendur, L. Medina Rodríguez, A. Italiano, I. Lugowska, I.L. Ray-Coquard, A.M. Oza, Jimmy L. Zhao, Srikanth Gajavelli, J. Filant, Shankar Bodla, Yelena Y. Janjigian, Funda Meric‐Bernstam